Study to Evaluate IMG-004 in Healthy Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of Orally Administered IMG-004 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Dose(s) and an Open-Label Study of Single Oral Dose of IMG-004 to Evaluate the Food Effect in Healthy Participants
Epistemonikos ID: cebebd8e9e40baed6c972adc2170c9182cbf1309
First added on: Oct 02, 2023